ABVC BioPharma, Inc. Restricted Cash
ABVC BioPharma, Inc. (ABVC) had Restricted Cash of $0 as of 2026-03-31, per its 10-Q filed 2026-05-18.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2026-05-18
- 2026-03-31: Restricted Cash $0.00.
- 2024-03-31: Restricted Cash $628.51K.
- 2023-12-31: Restricted Cash $656.63K.
- 2023-09-30: Restricted Cash $620.87K.
USD
| Period end | Restricted Cash |
|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-18 |
| 2024-03-31 | $628.51K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $656.63K 10-Q · filed 2024-05-17 |
| 2023-09-30 | $620.87K 10-Q · filed 2023-11-15 |
| 2022-12-31 | $1.31M 10-K · filed 2024-03-13 |
TWD
| Period end | Restricted Cash |
|---|---|
| 2025-03-31 | 20.20M TWD 10-Q · filed 2025-04-30 |
| 2024-12-31 | 20.20M TWD 10-Q · filed 2025-04-30 |